Exelixis (EXEL) Tops Q1 EPS by 25c, provides guidance
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $50.38 --0%
Financial Fact:
Loss from operations: -25.14M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Loss from operations: -25.14M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q1 EPS of $0.62, $0.25 better than the analyst estimate of $0.37. Revenue for the quarter came in at $555.4 million versus the consensus estimate of $495.3 million.
GUIDANCE:
Exelixis sees FY2025 revenue of $2.25-2.35 billion, versus the consensus of $2.252 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Rekor Systems, Inc. (REKR) Tops Q2 EPS by 3c
- Melco Resorts & Entertainment (MLCO) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
